News | October 23, 2013

SCAI Calls for Expanded Use of Medical Simulation

Lifelike training technology has potential to improve interventional cardiology training programs and patient care

October 23, 2013 — In a paper e-published in Catheterization and Cardiovascular Interventions, the Society for Cardiovascular Angiography and Interventions (SCAI) examined the current state of medical simulation in interventional cardiology and issued recommendations for expanding and standardizing the use of the lifelike training technology by practicing interventional cardiologists and fellows-in-training. The authors urged increased use and accessibility of simulation training, especially for highly complex procedures such as structural heart intervention and in areas where procedural volume is low. 
 
Use of medical simulation as a training tool has grown over the past decade, largely because it helps physicians overcome training challenges shared by many medical professions, including physician work-hour restrictions and the pace at which technology is evolving.
 
“Interventional cardiology is particularly well-suited for simulation because the procedures are complex, learning curves can be steep, and complications can be life-threatening. While simulation cannot replace real patient experience, it provides a safe arena to develop and refine skills that improves overall patient care,” said Sandy Green, M.D., Fellow of the American College of Cardiologists (FSCAI), lead author of the paper and interventional cardiologist, Geisinger Medical Center in Danville, Pa.
 
The recommendations included:
  • Developing standardized cases to include in simulation training programs that encompass the essential psychomotor and knowledge-based skill sets required of interventional cardiologists.
  • Integrating standardized curriculum that meets current evidenced-based learning standards of the Accreditation Council for Graduate Medical Education (ACGME) and Core Cardiovascular Training Symposium (COCATs).
  • Conducting large-scale studies to further evaluate the efficacy of using simulation training for learning new procedures and for maintaining competency of other procedures for both fellows and experienced clinicians.
  • Integrating formal simulation programs into annual meetings and other training programs for fellows and practicing physicians. 
 
“Simulation is a very helpful tool for physicians who work in an ever-changing technological and procedural environment, like interventional cardiology,” said John Messenger, M.D., FSCAI, associate professor of medicine, Division of Cardiology, University of Colorado, Denver and chair, Simulation Committee, SCAI. “Our hope is that these recommendations will encourage the expansion of simulation training programs for fellows and experienced clinicians alike, and as a result, enhance the quality of care we provide patients.”
 
To draw a valid assessment of the current state of medical simulation in interventional cardiology and help guide recommendations, the SCAI Simulation Committee surveyed 59 ACGME-accredited interventional cardiology programs, of which 14 reported using simulation as a teaching technique in their interventional cardiology fellowship courses. 
 
The survey found:
  • Most respondents agree simulators allow trainees to identify areas of improvement.
  • Simulators are beneficial for learning low-volume procedures.
  • Those surveyed thought simulators provide an objective assessment of technical competence. 
  • Participants expressed concern about the financial burden of using simulation and felt regional or central simulation centers could help ease this burden.
 
The authors found simulated procedures are most commonly used in endovascular procedures, while structural heart intervention holds the greatest potential for simulation-based training because of the lack of formalized training programs in the United States and the low procedure volume. Other simulated procedures, including coronary intervention, offer advanced simulation technology that challenge trainees with realistic clinical scenarios, such as heart attacks, multivessel coronary artery disease and chronic total occlusion.
 
For more information: www.scai.org
 

Related Content

Fujitsu VR Heart Simulator Viewer Features in University of Tokyo Lecture

Stereoscopic view with a heart viewer. Image courtesy of Fujitsu.

News | Simulators| September 21, 2017
September 21, 2017 — Fujitsu announced that the University of Tokyo recently used...
Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Overlay Init